Near East University announced that Delta (India) variant was not found in 19 cases diagnosed with COVID-686 in the February-June period. The Alpha (UK) variant remains dominant in the range of 60 to 80 percent on a monthly basis.
The Delta variant of SARS-CoV-2, first detected in India in February, continues to spread globally. Fears are also spreading that the Delta variant could lead a new wave of COVID-19 that could undermine health systems, reverse plans to lift restrictions, and potentially even reduce the effectiveness of vaccines. The variant analyzes performed by the Near East University in patients diagnosed with COVID-19 PCR positive in the February-June period reveal that the Delta Variant is not seen in the TRNC.
Alpha remains dominant in TRNC, Delta is not detected!
Near East University announced that Delta variant was not detected in the variant analyzes performed in 19 cases diagnosed as COVID-686 PCR positive in the April-June period in the TRNC. In the study conducted by the Near East University, it was determined that the Alpha variant maintained its dominance at a rate of 60 to 80 percent on a monthly basis in positive cases detected between February and June.
On May 10, the World Health Organization identified subsequences of the B. 2 mutation, including the Delta variant of SARS-CoV-1.617.2 (B.1.617), as "variants of concern." This classification indicates that a variant is more contagious, causes a more severe course of the disease, does not respond to treatment, and is difficult to diagnose with standard tests.
The Delta Variant was registered as the fourth variant declared by the WHO as a “variant of concern”. Other 'variants of concern' are Alpha variant (B.1.1.7) first detected in the UK, Beta (B.1.351) first detected in South Africa and Gamma (P.1) first detected in Brazil .
Delta variant moderately resistant to vaccine
The Delta Variant is considered to be moderately resistant to vaccines, especially in people who receive a single dose. A single dose of the AstraZeneca or Pfizer vaccine can only reduce a person's risk of developing COVID-22 symptoms caused by the Delta variant by 19 percent, according to results from a Public Health England study published May 33. This rate is 50 percent for the Alpha variant. With the second dose of AstraZeneca vaccine, the protection rate against Delta increases to 60 percent. This rate is measured as 66 percent in Alpha. Two doses of Pfizer vaccine provide 88 percent protection against Delta and 93 percent protection against Alpha.
Near East University: There is no Delta Variant in TRNC!Prof. Dr. Tamer Şanlıdağ: “Special measures should be taken to prevent the Delta variant from entering the country”
Near East University Acting Rector Prof. Dr. Tamer Şanlıdağ stated that the global spread of the Delta variant, which is moderately resistant to COVID-19 vaccines, is worrisome in terms of the course of the epidemic, and said, “During the period from February to June, we diagnosed as Delta, Beta and Gamma in 19 cases in the Near East University Hospital that we diagnosed as COVID-686. We did not find any variants of it,” he said. prof. Dr. Şanlıdağ said, “The fact that the Delta variant has not been seen in the TRNC creates great hope in terms of epidemic management. It is of great importance to take special measures to prevent this variant from entering the country. Emphasizing the importance of determining which variant is infected with patients diagnosed with COVID-19, Prof. Dr. Şanlıdağ said, “The ability of the SARS-CoV-2 PCR Diagnosis and Variant Analysis Kit, which we developed as the Near East University, to detect the Delta variant, as well as the Alpha, Beta and Gamma variants classified as worrying variants by the World Health Organization, is of great importance to the management of the epidemic process. will make a contribution.”